-
Edmund Richardson Wins Baillie Gifford Prize for 'Alexander' Biography
-
Pakistan Demands Grant-Based Climate Finance at COP31 to Avoid Debt Trap
-
BYD Drops Rotating Screens in New Models Due to Tech Limits
-
E Pellicci Pop-Up at Selfridges Brings Back Nostalgic School Cake
-
Ryanair Flight from Rome Makes Emergency Landing in Lisbon After Bomb Threat
-
Coronation Street's Debbie Webster Steps Down as Dementia Storyline Intensifies
-
Maltese President Visits London Hospital to Support Families Facing Medical Care Challenges
Featured
Last news
Medicus Pharma Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Company Highlights CD228V as its Principal Development Priority, Proposed SPAC Business Combination at ~ $135 Million Valuation for SkinJect® and Teverelix® as a Partner-Ready Program
Jaguar Health Reports Approval of All Proposals at November 2026 Special Meeting of Stockholders
SAN FRANCISCO, CA / ACCESS Newswire / November 6, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar" or the "Company") today announced the voting results of the Company's November 6, 2026 Special Meeting of Stockholders (the "Special Meeting").
New Jobs & Big Deals: Forman Mills Opens Ninth Illinois Location
Forman Mills Country Club Hills Grand Opening Thursday, November 19th at 9 AMLocation: 4050 183rd St., Country Club Hills, IL The Shops at Coopers Grove
Wipeboard Launches Ghost.Wipeboard.io, a Case Management Workspace Built for Paranormal Investigation Teams
A live evidence board, an automatic investigation log and a case file workbook in one place, with a free plan for solo investigators
Moderna Reports Third Quarter 2026 Financial Results and Provides Business Updates
Reports third quarter revenue of $1.3 billion, GAAP net income of $0.2 billion and GAAP diluted EPS of $0.38Increases 2026 expected revenue growth to 15%-25%, exceeding the previous expectation of up to 10% growthImproves 2026 GAAP operating expense outlook by approximately $0.2 billion from previous estimateIncreases 2026 expected ending cash balance to $8.1-$8.3 billionHighlights positive Phase 3 data for intismeran and U.S. FDA approval of mFLUSIVA, the Company's fifth approved product globally
Vogenx Reports Third Quarter 2026 Financial Results and Business Highlights
Advances PBH Development Program Following August 2026 Initial Public OfferingStrengthens Balance Sheet with $82.1 Million in Total Cash, Cash Equivalents, and Marketable Securities
BioScience Health Innovations, Inc. Announces Its Subsidiary Vitalcore Research has Executed Master Distribution Agreement with Rule Imports
Agreement adds $250,000 in research funding and a master distributor relationship to support product development and commercialization across Vitalcore, Best365Labs and related BHIC product platforms
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 06
LONDON, UK / ACCESS Newswire / November 6, 2026 / The Company announces that on 05 November 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.
Milky Lane Food Truck Makes First Penrith Appearance This Weekend
Milky Lane’s food truck arrives in Penrith for the first time this weekend, fulfilling long-standing local demand for the cult burger brand. The mobile outlet will operate at 121 Coreen Avenue on Friday and Saturday, serving its signature menu of burgers, PopKorn Chicken, and Weezys to residents who have previously been unable to access the brand's physical locations.
BioScience Health Innovations Announces Two Key Developments Supporting Diversified Growth and Expansion Strategy
Company to acquire 100% of Vitalcore as a wholly owned subsidiary and acquire a 40% ownership interest in an established customer platform serving targeted peptide and wellness buyers
Health Canada Authorizes Moderna's mRNA Influenza and Combination Influenza and COVID-19 Vaccines
Canada becomes the first country to authorize both Moderna's mRNA seasonal influenza vaccine, mFLUSIVA®, and combination influenza and COVID-19 vaccine, mCOFLU®
CV Sciences, Inc. To Announce Third Quarter 2026 Results On November 12, 2026
SAN DIEGO, CA / ACCESS Newswire / November 5, 2026 / CV Sciences, Inc. (OTCQB:CVSI) (the "Company", "CV Sciences", "our", "us" or "we"), a preeminent consumer wellness company specializing in hemp extracts and other proven, science-backed natural ingredients and products, today announced that it will release financial results for the third quarter ended September 30, 2026, after the stock market closes on Thursday, November 12, 2026. The Company will hold a conference call with the investment community at 1:30 p.m. Pacific Time (4:30 p.m. Eastern Time) that same day.
Protagonist Reports Third Quarter 2026 Financial Results and Provides Corporate Update
MIMRYLO™ (rusfertide) Approved by FDA for the Treatment of Erythrocytosis in Adults with Polycythemia Vera; Approval Triggered $275 Million in Payments to ProtagonistComprehensive Phase 2b Program with PN-881, an Oral IL-17 Antagonist for Psoriasis, Planned to Initiate in Early Q1 2027$300 Million Share Repurchase Program Announced in September 2026Cash, Cash Equivalents and Marketable Securities of $834.6 Million as of September 30, 2026
Groundswell Honors Rural Leaders With 2026 Rural Power Awards at Rural Renaissance Roadshow
Honorees Yinka Bode-George, Scott Hamilton, and Mark Trahant demonstrate how local voices can lead decisions about energy, land, and development in the places they call home.
Ready Set Fund Grow Platform Unlocks a $1.2B Distributed Sovereign Compute Asset Class by Deploying Decentralized AI Edge Infrastructure in Opportunity Zones
Unlocking a scalable digital infrastructure asset class-pairing 1,600-amp power infrastructure and high-density GPU compute with the federal tax incentives of Qualified Opportunity Zones.
Who Is the Best Facial Feminization Surgeon in the US?
The Best FFS Surgeon in the U.S. is Dr. Javad Sajan
VSee Health Announces 13 New Hospital Agreements Expected to Generate More Than $3 Million in Annual Revenue
Multi-year agreements expand iDoc subsidiary's delivery of tele-ICU services and teleradiology platform solutions
Kartoon Studios Announces $300 Million SPAC, Kartoon Studios Acquisition Corporation
EF Hutton will be Sole Underwriter
New to The Street Launches 12-Part Series to Market CleanGo Innovations' GreenGo Certified Green Chemistry Products Across the U.S. and MENA Regions
CleanGo Innovations Inc. (CSE: CGII, OTCQB: CLGOF) to reach oil and gas, pipeline, marine and heavy-industry buyers through Bloomberg Television and FOX Business, New York City billboards, a 6.6M+ subscriber YouTube network and global newsflow
Chervon Names Doug Palmer Vice President of Finance - Canada
TORONTO, ON / ACCESS Newswire / November 5, 2026 / Effective November 9, 2026, Chervon names Doug Palmer Vice President of Finance - Canada, reporting to Neil Harrison, Vice President and Managing Director of Chervon Canada. He will also have a dotted-line reporting relationship to Ryan Wang, Chief Financial Officer, Chervon NA.
Armanino Foods to Attend Upcoming Investor Conferences
PLEASANTON, CA / ACCESS Newswire / November 5, 2026 / Armanino Foods of Distinction, Inc. (OTCQX:AMNF), a leading producer and marketer of premium frozen Italian and specialty foods serving retail, foodservice and industrial customers across North America and select international markets, today announced that management will participate in three upcoming institutional investor conferences: the Stephens NASH26 Conference, the ROTH Deer Valley Event and the Planet MicroCap Invitational 2027.
Dermata Therapeutics Highlights Media Recognition of Tome Skincare Following Commercial Launch
- Tome Skincare featured in Cosmopolitan, Women's Wear Daily, AIR MAIL, and Thingtesting highlights Tome's growing recognition among leading beauty editors -
Aptevo Achieves Key Clinical Development Objective, Significantly Reducing Infusion-Related Reactions with Mipletamig in Frontline AML
Refined priming-dose regimen addresses important treatment-tolerability objective identified through FDA discussions, further strengthening mipletamig's readiness for Phase 2 developmentSubstantial reduction in infusion reaction frequency and severity improves the patient treatment experience without compromising planned therapeutic dosingAchievement builds on mipletamig's encouraging clinical activity and favorable safety profile as a potential addition to the current standard of care
Polaris Renewable Energy Announces Q3 2026 Results
TORONTO, ON / ACCESS Newswire / November 5, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to report its financial and operating results for the three and nine months ended September 30, 2026. This earnings release should be read in conjunction with the Company's consolidated financial statements and management's discussion and analysis, which are available on the Company's website at www.PolarisREI.com and have been posted on SEDAR+ at www.sedarplus.ca. The dollar figures below are denominated in US Dollars unless noted otherwise.
Polaris Renewable Energy Declares Quarterly Dividend
TORONTO, ON / ACCESS Newswire / November 5, 2026 / Polaris Renewable Energy Inc. (TSX:PIF) ("Polaris Renewable Energy" or the "Company"), is pleased to announce that its board of directors has declared a quarterly dividend of US$0.15 per common share outstanding.
Jerash Holdings (US), Inc. Declares Quarterly Dividend
FAIRFIELD, NJ / ACCESS Newswire / November 5, 2026 / Jerash Holdings (US), Inc. (Nasdaq:JRSH) (the "Company" or "Jerash"), which manufactures and exports custom, ready-made, sportswear and outerwear for leading global brands, announced today that its board of directors approved the payment of a regular quarterly dividend of $0.05 per share on the Company's common stock. The dividend is payable on or about November 23, 2026 to the stockholders of record as of November 16, 2026.
BioAdaptives to Acquire Xycota Biosciences to Pursue the Potential of At Home Psilocybin Treatment
Xycota's lead program aims to deliver clinical benefit from low-dose psilocybin without hallucinogenic effects, with mild PTSD as its initial target.
Cosmos Health's CosmoFarm Begins Commissioning New Automated Order-Processing and Vehicle-Loading Infrastructure, Advancing Capacity That Could Support Over $120 Million in Annual Revenue
New order-processing line: automated handling cell and roller conveyor now being commissioned at CosmoFarm's distribution center in Peristeri, Athens, designed to move more orders through the facility in less timeNew vehicle-loading lanes: multiple rows of roller flow lanes designed to significantly reduce the time needed to load each delivery vehicleEarlier dispatch: faster processing and loading are expected to get vehicles on the road sooner, supporting earlier pharmacy deliveries and capacity for additional routesAcquisition pipeline: CosmoFarm has an active letter of intent to acquire a network with approximately €10 million (approximately $11.3 million) in annual gross revenue, which, if completed, would be its largest acquisition to dateOngoing automation program: the new infrastructure is part of CosmoFarm's multi-year program in robotics, automation and artificial intelligence
InterContinental Hotels Group PLC Announces Transaction in Own Shares - November 05
LONDON, UK / ACCESS Newswire / November 5, 2026 / The Company announces that on 04 November 2026 it purchased the following number of its ordinary shares of 20340/399 pence each through Goldman Sachs International ("GSI") on the London Stock Exchange in accordance with the authority granted by shareholders at the Company's Annual General Meeting on 8 May 2025 (the "Purchase"). The Purchase was effected pursuant to instructions issued by the Company on 17 February 2026, as announced on 17 February 2026.
Former DEA Administrator Sounds Alarm on Drug Safety as Federal Marijuana Rescheduling Faces Critical November 5 Deadline
Duane Boise CEO MMJ International Holdings Points to Warnings from Former DEA Administrator Asa Hutchinson, the American Medical Association and GAO as Federal Courts Review Challenges to Marijuana PolicyMMJ's CMS Beneficiary Incentive Case Is on Appeal Before the U.S. Court of Appeals for the D.C. Circuit
Emerging Growth Research Reports Continued Revenue Growth at Immuron
NEW YORK CITY, NY / ACCESS Newswire / November 4, 2026 / Emerging Growth Research ("Emerging Growth Research" or "EGR") today announced the release of its company-sponsored research Flash Report on Immuron Limited (NASDAQ:IMRN), reiterating its Buy-Extended rating and updating its 12-month price target.
Viemed Healthcare Announces Third Quarter 2026 Financial Results
LAFAYETTE, LA / ACCESS Newswire / November 4, 2026 / Viemed Healthcare, Inc. (the "Company" or "Viemed") (NASDAQ:VMD), a national provider of technology-enabled, home-based healthcare solutions and chronic disease management, announced today that it has reported its financial results for the three and nine months ended September 30, 2026, and updated guidance for the full year ending December 31, 2026.